abstract |
The invention relates to novel compounds of formula (I) wherein R, R<1>, R<2>, R<3> and n have the meaning given in Claim 1. Said compounds are inhibitors of the coagulation factor Xa and can be used for the prophylaxis and/or therapy of thrombo-embolic diseases. |